Dr. Umemura is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2910 N 3rd Ave
Phoenix, AZ 85013Phone+1 734-647-8906Fax+1 734-232-4839
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Neuro-Oncology, 2015 - 2017
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Neurology, 2012 - 2015
One Brooklyn Health System/Brookdale University Hospital and Medical CenterInternship, Internal Medicine, 2011 - 2012
St. George's University School of MedicineClass of 2011
Certifications & Licensure
MI State Medical License 2017 - 2027
AZ State Medical License 2023 - 2026
NY State Medical License 2014 - 2018
NH State Medical License 2012 - 2016
PA State Medical License 2014 - 2015- American Board of Psychiatry and Neurology Neurology
- United Council for Neurologic SubspecialtiesNeuro-oncology
Clinical Trials
- Mycophenolate Mofetil Combined With Radiation Therapy in Glioblastoma Start of enrollment: 2020 Aug 05
- Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response Start of enrollment: 2016 Jul 12
Roles: Contact, Principal Investigator
- Study of Tirabrutinib (ONO-4059) in Patients With Primary Central Nervous System Lymphoma (PROSPECT Study) Start of enrollment: 2021 Dec 29
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 113 citationsPurine metabolism regulates DNA repair and therapy resistance in glioblastomaWeihua Zhou, Yangyang Yao, Andrew J. Scott, Kari Wilder-Romans, Joseph Dresser
Nature Communications. 2020-07-30 - 119 citationsPediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201.Andrew S. Chi, Rohinton Tarapore, Matthew Hall, Nicole Shonka, Sharon Gardner
Journal of Neuro-Oncology. 2019-10-01 - 32 citationsClinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways.Sriram Venneti, Abed Rahman Kawakibi, Sunjong Ji, Sebastian M Waszak, Stefan R Sweha
Cancer Discovery. 2023-11-01
Press Mentions
Ivy Brain Tumor Center Builds on Innovative Clinical Trial Program by Appointing New Chief Medical OfficerMay 23rd, 2023- Celebrating Women in MedicineFebruary 3rd, 2023
- A Brain Tumor at 27, and a Team That Changed Her LifeMarch 23rd, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
